He brought more than 30 years of experience as a clinical trials statistical consultant and researcher to the Alliance, becoming a key leader of the Cancer Control Program. In addition to furthering the work of many others, Dr. Sloan’s research showed that simple single item measures of patient QOL domains can predict duration of survival for cancer patients. This work led to routine incorporation of QOL measures into oncology clinical practice for every patient visit at Mayo.